Newly awarded German Growth Champion joimax® presents new products at DWG Stuttgart, Germany, and broadens its education and congress activities

IRVINE, CA – November 30, 2017 – joimax®, recently awarded as German Growth Champion 2018, continues to share its expertise in endoscopic minimally invasive spine surgery. With the latest workshops in Krasnodar, RUS, Guadalajara, Mexico and at the Wooridul Hospital in Korea, the company strengthens its outstanding education program. During the workshops, surgeons are trained in endoscopic techniques and other minimally-invasive procedures. Since the start of the cooperation with the Korean Wooridul group, the world’s largest specialized MISS – Endoscopic Spine Hospital Network, in 2017, a series of four courses, provided at different levels, have now been performed.

“Heavily increasing user interest and fast growing patient demand for endoscopic spinal surgery is leading to major needs, which joimax® is addressing by broadening its training program and presence at international congresses,” says Wolfgang Ries, Founder and CEO of joimax®.

Hence, joimax® again had an outstanding presence at the 12th International Congress of the Chinese Orthopedic Association (COA), which took place in Zhuhai, China, from Nov 15 – 18, 2017. In Vietnam, the first cervical surgery with the joimax® CESSYS® system was successfully performed by joimax® faculty Dr. Jun Seok Bae together with Dr. Dinh Ngoc Son, on Nov 22, 2017 at the Viet-Duc Hospital, the largest surgical center of Vietnam in Hanoi.

At the upcoming congress of the German Spine Society (DWG), taking place Nov 30 – Dec 02, 2017, in Stuttgart, Germany, joimax® will introduce its newest camera system called Camsource® LED combined with its latest Vitegra® Docu and Command Visual Integration System offering the highest resolution imaging with CMOS sensor technology. Additionally, the company will present its extended EndoLIF® portfolio with the new EndoLIF® Double-Wedge Cage, usable for TLIF- and ELIF-fusion techniques. joimax® will host two lunch symposia and hold “Meet-the-Expert” presentations at its booth.

At the same time, the company will have a booth with 2 workshop stations at the KOMISS (Korean Minimally Invasive Spine Surgery Society) International Symposium and Hands-on Cadaver Workshop for Endoscopic Spine Surgery, taking place from Dec 1 – 3 in Incheon, Korea. The year ends with another excellent workshop at the IRCAD Institute in Taiwan on Dec 22- 23, 2017.

joimax® reports another record in revenues globally in Q3/2017 and introduces new products at EUROSPINE in Dublin, Ireland and at NASS in Orlando, Florida

IRVINE, CA – October, 10, 2017 – Due to the fast growing user interest, but moreover the patient demand for endoscopic spinal surgery, joimax® sees another record in revenues in Q3/2017, with almost 60% of growth year over year, whereas joimax USA is almost doubling its revenues compared to 2016. “These results are also reflected in the huge interest at the SMISS Annual Forum which took place Sept 14- 16, 2017 in Las Vegas and the ISASS MIS Couse which took place Sept 22 – 23 in Long Beach, where joimax® as market leader supported the cadaveric lab sessions” explains Wolfgang Ries, Founder and CEO of joimax®. Key presenters at these meetings had been Albert Telfeian, MD, PhD, Brown Univ., RI and Jian Shen, MD, PhD, Nathan-Lattauer Hospital, NY, both excellent surgeons with great experience.

Now at EUROSPINE, taking place Oct 11 – 13 in Dublin, Ireland, joimax® will introduce its new Shrill® Deflector Blades for spinal decompression. By deflecting, the blades provide an outstanding work-around-the-corner technology. They are applicable for the various joimax® TESSYS® systems as well as for the fast adopting iLESSYS® Delta system.

Additionally, a range of new Vaporflex® bipolar forceps for TESSYS® and iLESSYS® applications will be introduced as well. Those instruments are available in two handle versions and equipped with three different electrodes. The product portfolio will be completed by new sets of bipolar tweezers for micro surgery. All these bipolar instruments can be used with the very successful globally launched Endovapor® RF/HF generator, which received FDA clearance in April 2017 as well. joimax® underlines its market leadership with a professional trade fair appearance with Meet-the-Expert sessions at the booth and by hosting a Faculty and DIstributor meeting prior to the conference in Dublin.

At NASS, for the first time ever, a full endoscopic spinal surgery session is included in the main program, held on October 26th in room WF3. The session is followed by an onsite cadaveric lab running from 5:10 PM – 8:00 PM with a full joimax® presence. In order to share the vast growing endoscopic user experience more widely, joimax® will hold a Meet-the-Expert presentations at the booth as well.

joimax® will wrap up its presence at NASS congress with an Expert meeting, including a wet lab, aiming to coordinate all training and education activities, specifically those which are related to US market needs.

joimax® , Inc. opens its first Education & Training Center in Irvine, California, posts record sales in the US and continues to make gains with endoscopic reimbursement

IRVINE, CA – August, 31, 2017– joimax® announces the grand opening of its new state-of-the-art Training and Education Center in Irvine, California. The company will be holding its first workshop at the Center on September 8-9th.

As the market leader in endoscopic spine surgery, joimax® is fully dedicated to outstanding physician education, training and services worldwide. Due to the newly released US CPT reimbursement code, valid since January 1st, 2017, the demand for joimax® endoscopic procedures are growing monthly in the USA among patients as well as the physician community. This fast growing demand creates major needs which joimax®, Inc. is addressing with fast expansion of its US organization.

“This new wet lab facility provides a major base for supporting our fast growing education needs for both our new sales and clinical associates, but moreover it’s a place for physicians to be trained,” states Bob Wolownik, National Director of Sales for joimax® Inc.

joimax® also announced that they are taking the lead in supporting this years’ workshops and educational sessions at:

SMISS Sept 14-16, 2017 – Las Vegas, NV – Sole Supporter of the Endoscopic Lab Session

ISASS Sept 22-23, 2017 – Long Beach, CA – Endoscopic Lab Supporter

NASS Oct. 25-28, 2017 – Orlando, FL – Endoscopic Spine Surgery Session Sponsor and Endoscopic Lab Supporter

jjoimax®  has also made significant strides in reimbursement support for endoscopic spine procedures via a new external coding support hotline that it manages along with a payor correspondence package. joimax® Inc.’s Vice President of Operations & Reimbursement, Brian Schneider, recently stated “We have seen a significant rise in interest from both payors and physicians asking to receive information and streamline communication regarding the new endoscopic spine code.”

“As we received a first CPT reimbursement code for endoscopic spine surgery earlier this year and now invest wisely for future growth, joimax® will continue to write a major success story in the US, similar to what it has accomplished in Europe and Asia, “ states Maximilian Ries, General Manager for joimax®, Inc. He announced that the company is continuing to post record sales by nearly doubling its year to date US revenues, which is in line with the companies’ budget plan.

Overall joimax® is very pleased with the great strides achieved in the US market and sees continued sustainable growth globally. “All this is an important step towards the full acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the physician and their patients in the US now as well,” echoes Wolfgang Ries, Founder and CEO of joimax®.

The company’s European and Asian sales also show record numbers. Earlier this year, joimax® also received multiple new product registrations in Asia and recently in Brazil to fully access this new market.

joimax® elevates its presence across Europe and Asia

Irvine, CA – June 7, 2017 – Over the last few weeks, joimax® participated in numerous scientific meetings, held across Europe and Asia. During these meetings, the German-based company reiterated its position as market leader for endoscopic minimally invasive spine surgery.

Starting in early May, joimax® exhibited at this years’ Global Spine Congress (GSC, http://www.gsc2017.org) in Milan, Italy, including a Meet-the-Expert Session at its booth and at the Intermediate Meeting of the World Congress of Minimally Invasive Spine Surgery and Techniques (WCMISST) in Paris, France. Numerous joimax® faculty members presented the latest results in endoscopic spine surgery.

From May 11 to 14, joimax® participated in the 10th Conference of the Chinese Association of Orthopedic Surgeons, held in cooperation with the North American Spine Society (CAOS/NASS) in Guangzhou, China. The conference was combined with a highly attended workshop on principles and techniques of complex spine surgery. This session was video transmitted to 20,000 hubs.

During the annual meeting of the German Society of Neurosurgery (DGNC) in Magdeburg, Germany, from May 14 to 17, joimax® exhibited its complete product range. The lunch symposium, covering the treatment options in endoscopic decompression and pain therapy, was presented by the well-recognized joimax® faculty members Drs. Erik Traupe, Guntram Krzok and Ralf Wagner.

From May 18 to 20, joimax® participated in the first International Spine Conference at the KCM clinic in Jelenia Gora, Poland, highlighting the achievements of modern endoscopic minimally invasive spine surgery. In live surgeries various endoscopic techniques in cervical and lumbar cases were performed. The session was coupled with a simultaneous discussion between surgeons and participants.

“The International Spine Conference in Poland marks the successful kick-off for the cooperation with our new partner to start extensive market activities in this country”, says Wolfgang Ries, Founder and CEO of joimax®. “Both, training and education, which also started in Poland, now are the key to success to further deepen the endoscopic knowledge of spine surgeons.”

In early June, the annual meeting of the International Society for the Study of the Lumbar Spine (ISSLS) took place in Athens, Greece, followed by the annual congress of the French Society of Spinal Surgery (Societé Francaise de Chirurgie Rachidienne, SFCR) in Lille, France. Both meetings attracted many spine specialists and generated good traffic at the joimax® booths.

Since its inception, joimax® participates in the European Course for Minimally Invasive Spinal Surgery (EUCMISS, http://www.eucmiss.com). This years’ 5th Course in Madrid, Spain, was held on June 1 and 2. It was a special course of globally leading experts in minimally invasive spine, exchanging the practical and scientific experience in presentation and multidisciplinary cadaver courses.

joimax® will continue its activities by exhibiting at the NSpine Main Conference in London, UK, from June 12 to 15 and then they head back to Asia to attend the 6th Asian Conference of Minimally Invasive Spine Surgery Techniques (ACMISST) in Bangkok, Thailand between June 29 and July 2 with a faculty presentation and a booth presence.

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax® Vaporflex® and Legato® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax®.

During the AANS, joimax®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.

joimax® celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and iLESSYS® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax® and Qin-Guang You, President of joimax® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax® Handshake Award in Silver.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax®.

joimax® obtains full product registration in Thailand, and is now active in 10 Asian countries

Karlsruhe, Germany – February 27th, 2017joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax® also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax® products. Thus, joimax® is well prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest growing region of the world,” states Wolfgang Ries, Founder and CEO of joimax®.

For years, joimax® has been working with the Korean Wooridul group, the world’s largest Specialized Spine Hospital Network. Starting in 2017, joimax®, together with the Wooridul Hospital in Seoul, will offer International courses for Minimally Invasive Spinal Surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax® faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.

After the National Minimal Invasive Spinal Summit Forum, together with the 4th joimax® User Meeting in December, joimax® China, headquartered in Chengdu, will celebrate its 10th birthday in April 2017. On this occasion, numerous internationally well-known faculties will meet in Chongqing, China to share experience and expertise. Lectures and live surgeries are planned to be held in two hospitals and to be broadcasted via Internet.

Participants of the National Minimal Invasive Spinal Summit Forum & 4th joimax User Meeting, held in Zhenghou City, China from Dec. 23rd until 25th, 2016

joimax® shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

Karlsruhe, Germany – January 17th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax® procedures.

joimax® is active in 45 countries by now and meanwhile enjoys a strong reputation in Europe and also in Asia which will now spread out into the US-market as well. “The entry in force of the CPT 2017 reimbursement Codebook (Current Procedural Terminology) as of January 1st, 2017, is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques. The codebook now contains the first endoscopic spinal surgery code, under which the specific transforaminal (TESSYS®) and/or interlaminar (iLESSYS®) procedures marketed by joimax® are now eligible in the USA and this will further contribute to fully increase sales in the US as well” states Wolfgang Ries, Founder and CEO of joimax®.

joimax® technologies are based on worldwide intellectual property and the company holds now more than 150 patents and trademarks. Only in 2016 18 patents and patent publications were issued to joimax®. The latest one is Patent No. EP 2 983 622 for the EndoLIF® Cage, which has been introduced to offer a minimally invasive as well as open (TLIF) alternative for fusion in the lumbar spine as an optimal treatment option for surgeons.

The company is busy on inventing and innovating next minimally invasive systems with regards to newer implants based on the EndoLIF® technology but also decompression methods based on its endoscopic systems. This will now be completed with Intracs®, the new Interaoperative Navigation Tracking & Control System with which joimax® instruments can be navigated directly at the tip. The Intracs® Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF® (Lumbar Interbody Fusion) and Percusys® (Percutaneous Screw-Rod Stabilization).